All products Quality & compliance Resources About Contact
Request a quote

Monensin Sodium

Monensin A sodium salt, ionophore antibiotic · CAS 22373-78-0

Veterinary Veterinary grade / EP (vet) CoA per batchSDSMRL guidance note

An ionophore with a real toxicity margin problem — it is lethal to horses at feed-level doses, so cross-contamination control in the mill is part of the product. Assayed as monensin A on the dried basis.

Part of the anticoccidial line, dosed in parts per million — homogeneity in the premix matters more than the assay.

Identity

Catalogue no.BP-VET-012
CAS number22373-78-0
Molecular formulaC36H61NaO11
Molecular weight692.86 g/mol
HS code2941.90
SynonymsMonensin A sodium salt, ionophore antibiotic
Product lineVeterinary APIs
CategoryAnticoccidials

Release specification

Catalogue standard below. For a supply agreement we release against your dossier specification; send it with the enquiry and the CoA will be built around it.

ParameterSpecification
Assay90.0–95.0%
Related substancesMonensin A ≥ 90.0% of the declared potency; any unspecified impurity ≤ 3.0%
Water content≤ 0.5% (Karl Fischer)
Heavy metals≤ 20 ppm (ICP-MS)
PotencyExpressed as monensin A sodium salt

Application

Ionophore coccidiostat and rumen fermentation modifier in cattle, poultry and goats.

Packaging, storage & logistics

Standard packaging25 kg fibre drum with double PE liner
Minimum order25 kg
Lead time25–40 days
Storage conditionsStore below 25 °C, protected from moisture
Shipping documentsInvoice, packing list, CoA, SDS, certificate of origin; DGM/IATA declaration where applicable

Pack sizes available — pick one to prefill the enquiry

Documentation provided

  • CoA per batchBatch-specific, tested against the specification agreed at PO stage
  • SDSCurrent GHS revision; destination-language version on request
  • MRL guidance noteMaximum residue limit and withdrawal-period reference for the destination market

Need the DMF open part, a sample CoA or an audit pack before you can qualify us? Ask on the enquiry form — we send those documents before any commercial discussion.

Request a quotation

Submitting opens your email client with these details filled in, so the enquiry reaches gm@bioranpharma.com directly. We use your details only to answer this enquiry — see privacy & data use.

Related products